OxyContin®
(controlled release; Purdue)
FDA approved indications: 12.12.1995 management of moderate to severe pain when a continuous,
around-the clock analgesic is needed for an extended period of time U.S. Prescribing information
OxyFast®
(concentrate; Purdue)
FDA approved indications: analgesia
OxyIR®
(immediate release; Purdue)
FDA approved indications: analgesia
Roxicodone™
sustained release(Roxane)FDA approved indications:
10.26.98 For the management of moderate to severe pain where use of an
opioid analgesic is appropriate for more than a few days